A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial
US National Institutes of Health Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) and the National Institute of Allergy and Infectious Diseases.
Authors
- Alberto Mendoza‐Ticona (ORCID: https://orcid.org/0000-0002-2571-2894)
- Kimberly K. Scarsi (ORCID: https://orcid.org/0000-0001-9406-693X)
- William Murtaugh
- Justine Beck
- Maria L. Wei (ORCID: https://orcid.org/0000-0002-3568-1921)
- Joan Du Plessis
- Elin M. Svensson (ORCID: https://orcid.org/0000-0002-0093-6445)
- Luke Hall
- David W. Haas (ORCID: https://orcid.org/0000-0002-5813-1594)
- John Metcalfe (ORCID: https://orcid.org/0000-0002-2279-7036)
- Jennifer Furin (ORCID: https://orcid.org/0000-0002-0825-7199)
- Simon E. Koele (ORCID: https://orcid.org/0000-0002-7011-667X)
- Gary Maartens (ORCID: https://orcid.org/0000-0003-3080-6606)
- Wadzanai Samaneka (ORCID: https://orcid.org/0000-0003-0215-9309)
- Jorge Leon-Cruz
- Brian Clagett (ORCID: https://orcid.org/0009-0006-4046-125X)
- Gus R. Rosania (ORCID: https://orcid.org/0000-0003-3214-5565)
- Afton Dorasamy
- Melanie Goth
- Kevin Knowles
- Richard E. Chaisson (ORCID: https://orcid.org/0000-0003-4710-925X)
- Samuel Pierre (ORCID: https://orcid.org/0000-0001-8063-8773)
- Isabelle R. Weir (ORCID: https://orcid.org/0000-0002-5098-0671)
- Neeta Pradhan (ORCID: https://orcid.org/0000-0002-9696-3228)
- Neetal Nevrekar (ORCID: https://orcid.org/0000-0001-8496-5341)
- Cecilia Kanyama (ORCID: https://orcid.org/0000-0002-8251-9169)
- Barbara M. Altman
- Jean Bernard Marc (ORCID: https://orcid.org/0009-0008-1428-5015)
- Natthapol Kosashunhanan (ORCID: https://orcid.org/0000-0002-5273-4976)
- J. Blair Meldrum
- Maxwell Yohane
- Austin Van Grack
- Rahul Lokande
- Busisiwe Ntsalaze
- Anne Wambui Njorge
Institutions
- Nebraska Medical Center (US)
- Johns Hopkins University (US)
- University of Cape Town (ZA)
- B. J. Medical College & Sassoon Hospital (IN)
- Johns Hopkins Medicine (US)
- Cancer Research And Biostatistics (US)
- EsSALUD (PE)
- Blantyre Institute for Community Ophthalmology (MW)
- National Institute of Allergy and Infectious Diseases (US)
- Gheskio Centers (HT)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- The Lancet Infectious Diseases
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1016/s1473-3099(25)00436-0
- Citations
- 2
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- National Institute of Allergy and Infectious Diseases